RO-7538483
N/A
Report date: 2024/04/26 20:00:28
Base Information
Drug NameRO-7538483
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[11]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesF. Hoffmann-La Roche LtdRoche (China) Holding Ltd
China Registration ClassN/A
Develop Information
Active CompaniesF. Hoffmann-La Roche LtdGenentech IncRoche (China) Holding Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A